Avid Bioservices Inc (CDMO)

[honestabe13]

it is not a no-brainer!

for example, if they get through the p3 without a partner and the results aren't at least as good as they were with what was salvaged from p2, we're screwed. where do you think the pps would be then? p3s fail to duplicate p2 results MOST of the time. don't forget that.

all the new knowledge is PRE-CLINICAL...that is, YEARS from validation in humans. by then, something else could well come along, making this stuff less valuable in the marketplace than it is now (which isn't much), before more dilution!!!!!!

it MAY be a home run, but the finish line for this never gets any closer with this management team.